Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo

12 Feb 2025

Abstract excerpt

BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies in patients with thromboembolic/thromboinflammatory events and/or obstetric complications. OBJECTIVES: The aim of this study was to examine whether there are alterations in the platelet lipidome of APS patients in comparison with patients affected by thromboembolism without APS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Platelet Disorders and Treatments
Share to Systemic Lupus Erythematosus Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39952362
DOI: 10.1016/j.jtha.2025.01.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivoPMID 39952362Read ↗

Platelets and Thrombotic Antiphospholipid SyndromeSemantic proximity Read ↗

Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.Semantic proximity Read ↗

Common anti-platelet therapies modulate procoagulant phospholipids in arterial diseaseSemantic proximity Read ↗

Thrombin generation is associated with extracellular vesicle and leukocyte lipid membranes in acute coronary syndromeSemantic proximity Read ↗

Extracellular Vesicles in the Antiphospholipid SyndromeSemantic proximity Read ↗

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?Semantic proximity Read ↗

ANTIPHOSPHOLIPID SYNDROME AS A MODIFIER OF CLINICAL PHENOTYPES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A CASE-CONTROL STUDY.Semantic proximity Read ↗

Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping reviewSemantic proximity Read ↗

TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.Semantic proximity Read ↗

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic MechanismsSemantic proximity Read ↗

The Antiphospholipid SyndromeSemantic proximity Read ↗

Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.